Episode
Accountability, Innovation, and Access Across Care | TWIRx
- Podcast
- Pharmacy Podcast Network
- Published
- Apr 10, 2026
- Duration seconds
- 2165
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/pharmacy-podcast-network-945715/episodes/accountability-innovation-and-access-across-care-twirx/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/pharmacy-podcast-network-945715/accountability-innovation-and-access-across-care-twirx.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This Week in Pharmacy 04-10-2026Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC)On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy’s biggest gatherings of the year.This week’s episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance.In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy.First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period.Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year’s conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management.We also spotlight a powerful research update…